Integrated breast cancer genomics
- PMID: 17157784
- DOI: 10.1016/j.ccr.2006.11.007
Integrated breast cancer genomics
Abstract
Predicting survival and therapy responses of breast cancer patients is a significant challenge. Two studies in this issue of Cancer Cell present a novel integrated analysis of genomic and transcriptomic profiles of 145 primary breast cancers and 51 established cell lines. Data from clinical tumors highlighted mechanisms of disease and facilitated identification of potential therapeutic targets and prognostic biomarkers. An extensive well-characterized cancer cell line resource opens up opportunities to explore the determinants of cellular responses to existing and emerging therapies. Taken together, these studies illustrate how integrated molecular profiling may one day significantly impact diagnosis and therapeutic choice in human breast cancer.
Comment on
-
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.Cancer Cell. 2006 Dec;10(6):515-27. doi: 10.1016/j.ccr.2006.10.008. Cancer Cell. 2006. PMID: 17157791 Free PMC article.
-
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.Cancer Cell. 2006 Dec;10(6):529-41. doi: 10.1016/j.ccr.2006.10.009. Cancer Cell. 2006. PMID: 17157792
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
